The anti-inflammatory effects of ulinastatin in trauma patients with hemorrhagic shock

Journal of Korean Medical Science

Volumn 25, Issue 1, 2010, Pages 128-134

  Park, Kyung Hye ^a   Lee, Kang Hyun ^b   Kim, Hyun ^b   Hwang, Sung Oh ^b  

^a Jeju National University   (South Korea)

^b Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Hemorrhagic; Interleukin 6; Leukocyte elastase; Shock; Tumor necrosis factor alpha; Ulinastatin

Indexed keywords

GLYCOPROTEIN; INTERLEUKIN 6; LEUKOCYTE ELASTASE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMORRHAGIC SHOCK; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; GLYCOPROTEINS; HUMANS; INTERLEUKIN-6; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SHOCK, HEMORRHAGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949333197     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.1.128     Document Type: Article

References (25)

1. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000; 26 (Suppl 1): S64-74.
2. Maitra SR, Gestring M, el-Maghrabi MR. Alternations in hepatic 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and glucose-6-phosphatase gene expression after hemorrhagic hypotension and resuscitation. Shock 1997; 8: 385-8.
3. Lee CC, Marill KA, Carter WA, Crupi RS. A current concept of trauma-induced multiorgan failure. Ann Emerg Med 2001; 38: 170-6.
4. Riedemann NC, Neff TA, Guo RF, Bernacki KD, Laudes IJ, Sarma JV, Lambris JD, Ward PA. Protective effects of IL-6 blockade in sepsis are linked to reduced c5a receptor expression. J Immunol 2003; 170: 503-7.
5. Nishiyama T, Hanaoka K. Do the effects of a protease inhibitor, ulinastatin, on elastase release by blood transfusion depend on interleukin 6? Crit Care Med 2001; 29: 2106-10.
6. Aosasa S, Ono S, Mochizuki H, Tsujimoto H, Ueno C, Matsumoto A. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor a production of monocytes. Shock 2001; 15: 101-5.
7. Sato Y, Ishikawa S, Otaki A, Takahashi T, Hasegawa Y, Suzuki M, Yamagishi T, Morishita Y. Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin. Inhibiting cytokines and postoperative organ injury. Jpn J Thorac Cardiovasc Surg 2000; 48: 428-34.
8. Chen CC, Liu ZM, Wang HH, He W, Wang Y, Wu WD. Effect of ulinastatin on renal ischemia-reperfusion injury in rats. Acta Pharmacol Sin 2004; 25: 1334-40.
9. Ohnishi H, Suzuki K, Niho T, Ito C, Yamaguchi K. Protective effects of urinary trypsin inhibitor in experimental shock. Jpn J Pharmacol 1985; 39: 137-44.
10. Fries E, Blom AM. Bikunin-not just a plasma proteinase inhibitor. Int J Biochem Cell Biol 2000; 32: 125-37.
11. Pugia MJ, Lott JA. Pathophysiology and diagnostic value of urinary trypsin inhibitors. Clin Chem Lab Med 2005; 43: 1-16.
12. Yano T, Anraku S, Nakayama R, Ushijima K. Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats. Anesthesiology 2003; 98: 465-73.
13. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Sekine I. Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury. J Leukoc Biol 2001; 69: 241-7.
14. Tani T, Aoki H, Yoshioka T, Lin KJ, Kodama M. Treatment of septic shock with a protease inhibitor in a canine model: a prospective, randomized, controlled trial. Crit Care Med 1993; 21: 925-30.
15. Tani T, Abe H, Endo Y, Hanasawa K, Kodama M. Effects of a urinary trypsin inhibitor on acute circulatory insufficiency after surgical operation. Am J Surg 1998; 175: 142-5.
16. Nishiyama T, Yokoyama T, Yamashita K. Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery. J Anesth 2006; 20: 179-82.
17. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-91.
18. Toth B, Yokoyama Y, Schwacha MG, George RL, Rue LW 3rd, Bland KI, Chaudry IH. Insights into the role of interleukin-6 in the induction of hepatic injury after trauma-hemorrhagic shock. J Appl Physiol 2004; 97: 2184-9.
19. Witthaut R, Busch C, Fraunberger P, Walli A, Seidel D, Pilz G, Stuttmann R, Speichermann N, Verner L, Werdan K. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis associated left ventricular dysfunction. Intensive Care Med 2003; 29: 1696-702.
20. Duswald KH, Jochum M, Schramm W, Fritz H. Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery. Surgery 1985; 98: 892-9.
21. Pacholok SG, Davies P, Dorn C, Finke P, Hanlon WA, Mumford RA, Humes JL. Formation of polymorphonuclear leukocyte elastase: alpha 1 proteinase inhibitor complex and A alpha (1-21) fibrinopeptide in human blood stimulated with the calcium ionophore A23187. A model to characterize inhibitors of polymorphonuclear leukocyte elastase. Biochem Pharmacol 1995; 49: 1513-20.
22. Mania-Pramanik J, Potdar SS, Vadigoppula A, Sawant S. Elastase: a predictive marker of inflammation and/or infection. J Clin Lab Anal 2004; 18: 153-8.
23. Ogawa M, Nishibe S, Mori T, Neumann S. Effect of human urinary trypsin inhibitor on granulocyte elastase activity. Res Commun Chem Pathol Pharmacol 1987; 55: 271-4.
24. Vallejo JG, Nemoto S, Ishiyama M, Yu B, Knuefermann P, Diwan A, Baker JS, Defreitas JS, Tweardy DJ, Mann DL. Functional significance of inflammatory mediators in a murine model of resuscitated hemorrhagic shock. Am J Physiol Heart Circ Physiol 2005; 288: H1272-7.
25. Neumann S, Gunzer G, Hennrich N, Lang H. "PMN-elastase assay": enzyme immunoassay for human polymorphonuclear elastase complexed with alpha 1-proteinase inhibitor. J Clin Chem Clin Biochem 1984; 22: 693-7.